HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Asprosin aggravates vascular endothelial dysfunction via disturbing mitochondrial dynamics in obesity models.

AbstractOBJECTIVE:
The aim of the study was to investigate the contribution of asprosin (ASP), a fasting-induced hormone involved in metabolic disorders, to vascular endothelial dysfunction in obesity models.
METHODS:
Primary rat thoracic aortic endothelial cells treated with palmitic acid and mice fed with a high-fat diet (HFD) were used as the obesity models. The role and mechanism of ASP in endothelial dysfunction were investigated by the means of morphologic, functional, and genetic analysis.
RESULTS:
ASP aggravated the endothelial dysfunction induced by either palmitic acid in vitro or an HFD in vivo, characterized as the impairment of endothelium-dependent vasodilation, reduction of nitric oxide levels, elevation of malondialdehyde levels, and inhibition of phosphoinositide 3-kinase-AKT-endothelial nitric oxide synthase signaling. However, adipose conditional knockout of ASP or ASP neutralization significantly alleviated the endothelial dysfunction induced by an HFD. Mechanistically, ASP enhanced mitochondrial fission, and inhibition of the fission through knockdown of dynamin-related protein 1 (a fission-hallmark factor) rescued the endothelial dysfunction and the disturbance to mitochondrial dynamics induced by ASP.
CONCLUSIONS:
The findings demonstrate that ASP causes and even exacerbates vascular endothelial dysfunction through promoting mitochondrial fission in obesity, suggesting that ASP can act as an early predictive marker of blood vessel dysfunction and become a novel potential therapeutic target for obesity-related cardiovascular diseases.
AuthorsYanli Lu, Wanwan Yuan, Xiaowei Xiong, Qianqian Huang, Sheng Chen, Tingting Yin, Yanan Zhang, Zhie Wang, Guohua Zeng, Qiren Huang
JournalObesity (Silver Spring, Md.) (Obesity (Silver Spring)) Vol. 31 Issue 3 Pg. 732-743 (03 2023) ISSN: 1930-739X [Electronic] United States
PMID36693798 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2023 The Obesity Society.
Chemical References
  • Nitric Oxide Synthase Type III
  • Palmitic Acid
  • Phosphatidylinositol 3-Kinases
  • Fbn1 protein, mouse
  • Fbn1 protein, rat
Topics
  • Animals
  • Mice
  • Rats
  • Diet, High-Fat
  • Endothelial Cells (metabolism)
  • Endothelium, Vascular
  • Mice, Inbred C57BL
  • Mitochondrial Dynamics
  • Nitric Oxide Synthase Type III (metabolism)
  • Obesity (metabolism)
  • Palmitic Acid
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Vasodilation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: